This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
Drug leader in acquisition talks
Modified-release tacrolimus: a new once-daily immunosuppressant for transplant recipients
RoACTEMRA approved in Europe to treat RA
PAGB welcomes the review of medicines misuse
Drug therapy boosts survival rates
Four major drug approvals for Novartis
Babies exposed to dangerous drugs
NHS makes cancer medicine free
FDA issues complete response letter for iclaprim
Radical therapies get top billing
Images record bleeding inside heart
Focus on preventative cancer drug
« Previous
1
…
155
156
157
158
159
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: